⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TECX News
Tectonic Therapeutic, Inc. Common Stock
Form 8-K
sec.gov
TECX
Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and PK Results for TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)
globenewswire.com
TECX
Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference
globenewswire.com
TECX
Form 8-K
sec.gov
TECX
Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights
globenewswire.com
TECX
Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights
globenewswire.com
TECX
Form 8-K
sec.gov
TECX
Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients
globenewswire.com
TECX
Form 8-K
sec.gov
TECX
Tectonic Therapeutic Announces First Quarter 2026 Financial Results and Recent Business Highlights
globenewswire.com
TECX